Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR) Listening Session

Formal title: U.S. Department of Health and Human Services (HHS) to hold an informal Stakeholder Listening Session on Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR)

Notice of Public Stakeholder Listening Session


Brief Description:

The United States Department of HHS announced that they will hold an informal Stakeholder Listening Session on Monday June, 7, 2010, in the Great Hall of the HHS Hubert H. Humphrey Building. The Stakeholder Listening Session will provide HHS with information, knowledge, ideas, feedback, and suggestions from all communities interested in the work of the TATFAR. The listening session will be organized around the focus areas specified in the November 2009 US-EU Summit Declaration:

  • appropriate therapeutic use of antimicrobial drugs in the medical and veterinary communities
  • prevention of both healthcare and community-associated drug-resistant infections
  • strategies for improving the pipeline of new antimicrobial drugs

AVMA Response:

The AVMA appreciates this opportunity to provide feedback on the mandate of the TATFAR. The AVMA applauds the Task Force's mandate to focus on the issue of appropriate uses of antimicrobial drugs in the medical and veterinary communities. We urge the Task Force to seek stakeholder input and promote collaboration between human and animal health professionals. The AVMA recognizes that health care-associated and community-associated resistant infections are significant concerns in the human health community. As veterinarians, trained in population medicine, we also agree that prevention of the development and transmission of infectious diseases including resistant infections are paramount to the practice of medicine. We commend the Task Force mandate and would greatly appreciate the opportunity to have an open dialogue and exchange of knowledge with our colleagues in the EU human and veterinary medical communities.

The AVMA has historically and continues to be a strong advocate for the development of new antimicrobials. The AVMA was a key stakeholder in the development of the Public Health Action Plan to Combat Antimicrobial Resistance that addresses the same focus areas as the TATFAR. Since the development of the Action Plan, the AVMA has consistently been supportive of the plan and advocated for funding to fully implement the plan. The AVMA thanks the Department of Health and Human Services for hosting the stakeholder Listening Session and we welcome the opportunity to be a resource for the task force.

Background Documents:

November 2009 US-EU Summit Declaration (PDF)

Notice from HHS regarding public listening session (PDF)

The AVMA responded on June 7, 2010. (PDF)